Reckamp Karen L, Koczywas Marianna, Cristea Mihaela C, Dowell Jonathan E, Wang He-Jing, Gardner Brian K, Milne Ginger L, Figlin Robert A, Fishbein Michael C, Elashoff Robert M, Dubinett Steven M, Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer, Cancer, 2015, 121 (18), 3298-306.